JACLYN BRABEC: Open Payments
NPI 1710343686 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,993 in 94 payments from 20 companies in 2025. Trend: 2023 $650 · 2024 $852 · 2025 $1,993
Food & beverage: $1,993
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $306 |
| ABBVIE INC. | 15 | $297 |
| UCB, Inc. | 10 | $253 |
| REVANCE THERAPEUTICS, INC. | 3 | $231 |
| Organon LLC | 17 | $229 |
| Incyte Corporation | 5 | $114 |
| GENZYME CORPORATION | 4 | $107 |
| Arcutis Biotherapeutics, Inc. | 3 | $65 |
| Galderma Laboratories, L.P. | 4 | $65 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 3 | $54 |
Products named: TREMFYA, SKYRIZI, Bimzelx, DAXXIFY, VTAMA, DUPIXENT, OPZELURA, Zoryve.
Industry payments across AZ — which companies pay providers there.
